openPR Logo
Press release

Key Trend Reshaping the Bexsero Market in 2025: Advancements In Meningococcal B Vaccine Development For Broader Protection

03-26-2025 05:38 AM CET | Health & Medicine

Press release from: The Business Research Company

Bexsero

Bexsero

What industry-specific factors are fueling the growth of the bexsero market?
The escalating incidence of meningitis is projected to fuel the expansion of the bexsero market in the coming years. Meningitis refers to the inflammation of the protective layers surrounding the brain and spinal cord, typically caused by an infection. This increase in meningitis cases can be credited to various elements, such as elevated infection rates, alterations in vaccination utilization, compromised immunity, and enhanced diagnostic and reporting practices. Bexsero aids in safeguarding against meningitis by prompting the immune system to generate antibodies that are aimed at Neisseria meningitidis group B bacteria, thereby lowering the possibility of invasive meningococcal disease, which can induce potentially fatal inflammation of the brain and spinal cord membranes. For example, according to the UK Health Security Agency (UKHSA), in August 2024, there were 396 confirmed cases of invasive meningococcal disease (IMD) in 2022-2023, more than the 205 cases reported during 2021-2022 by the Meningococcal Reference Unit (MRU). From 2022 to 2023, 356 cases of MenB invasive disease were verified, marking a substantial leap from 179 cases in 2021-2022 and just 61 cases during 2020-2021. Therefore, the escalating incidence of meningitis is fuelling the expansion of the bexsero market.

Get Your Bexsero Market Report Here:
https://www.thebusinessresearchcompany.com/report/bexsero-global-market-report

What Is the projected market size and growth rate for the bexsero market?
In recent times, the market size of Bexsero has experienced a growth of XX (HCAGR). The market is projected to expand from $XX million in 2024 to $XX million in 2025, advancing at a compound annual growth rate (CAGR) of XX%. The market expansion during the historical period can be linked to the escalated disease load, the surge in demand for meningococcal vaccines, a robust healthcare framework, heightened demand for vaccines overall and a rise in disease awareness.

Expectations are that the Bexsero market size will experience an XX% (FCAGR) upturn in the years to come, escalating to $XX million by 2029 at a CAGR of XX%. This anticipated growth within the forecast period can be linked to the rising occurrence of meningitis, an intensified focus on research and development, a heightened emphasis on preventive healthcare, the expansion of immunization programs, and growing acceptance of vaccines among parents. The forecast period's primary trends encompass advances in medicare, government initiatives, the development of mRNA (menB) vaccine technology, advances in vaccine creation, and the introduction of new vaccine delivery methods.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19998&type=smp

What new trends are reshaping the bexsero market and its opportunities?
Innovation in product creation is a primary trend within the Bexsero market, for example, the introduction of the Meningococcal B vaccine to provide comprehensive defense against diverse strains of the serogroup B. The Meningococcal B vaccine has been developed as a protection measure against Neisseria meningitidis serogroup B, a bacterial agent that causes invasive meningococcal disease, including meningitis and infections in the bloodstream. As an example, in July 2024, the Bexsero vaccine was launched in South Korea by the UK-based pharmaceutical company, GlaxoSmithKline (GSK) Plc. This vaccine contains four main recombinant proteins: NHBA, NadA, fHbp, and the outer membrane vesicle PorA P1.4, selected as a result of thorough genetic analysis of meningococcal B. The formulation, as it stands, initiates the production of bactericidal antibodies, targeting various methods of meningococcal B antigens.

What major market segments define the scope and growth of the bexsero market?
The bexsero market covered in this report is segmented -

1) By Formulation: Injectable Suspension, Pre-Filled Syringes
2) By Distribution: Hospitals, Pharmacy Stores, Public Health Programs
3) By End User: Adults, Geriatric, Adolescents, Children

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19998

Which region dominates the bexsero market?
North America was the largest region in the bexsero market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bexsero market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which key market leaders are driving the bexsero industry growth?
Major companies operating in the bexsero market include GlaxoSmithKline plc

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=19998&type=smp

What Is Covered In The Bexsero Global Market Report?

•Market Size Forecast: Examine the bexsero market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the bexsero market for a structured understanding.
•Key Players Overview: Analyze major players in the bexsero market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the bexsero market.
•Segment Contributions: Evaluate how different segments drive overall growth in the bexsero market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the bexsero market.
•Industry Challenges: Identify potential risks and obstacles affecting the bexsero market.
•Competitive Landscape: Review strategic developments in the bexsero market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Key Trend Reshaping the Bexsero Market in 2025: Advancements In Meningococcal B Vaccine Development For Broader Protection here

News-ID: 3937672 • Views:

More Releases from The Business Research Company

Company Registration Service Market Landscape 2025: Forecast Data and Growth Strategy Insights
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Company Registration Service Market Through 2025? The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecasts, and Growth Drivers
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025? In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market in 2025: Advancement In Digital Insurance Platforms Transforms Small And Medium Enterprises Coverage With Integrated, Data-Driven Solutions
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025? The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due To Rising Environmental Monitoring Requirements: Strengthening the Growth Trajectory of the Combustion Emissions Analyzer Market
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025? In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth

All 5 Releases


More Releases for Bexsero

Bexsero Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportuniti …
The Bexsero Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Bexsero Market? The market size of Bexsero has seen a XX (HCAGR) surge in the most recent years. The forecast indicates a growth from $XX million in 2024 to
Leading Element Driving Change in the Bexsero Market in 2025: Rising Meningitis …
"What Is the Expected Size and Growth Rate of the Bexsero Market? The size of the Bexsero market has experienced a $XX in the past few years. It's projected to escalate from a value of $XX million in 2024 to $XX million in 2025 with a Compound Annual Growth Rate (CAGR) of $XX%. Factors contributing to this growth in the historic period include a higher disease load, greater need for meningococcal
Global Meningococcal Vaccine Market : PEST and Key Players Analysis during the f …
The Global Meningococcal Vaccine Market accounted for US$ 3.0 Billion in 2020 and is estimated to be US$ 7.4 Billion by 2030 and is anticipated to register a CAGR of 9.5%. Centers for Disease Control and Prevention (CDC) recommends meningococcal vaccination for all preteens and teens, which includes all 11 to 12 year olds should get a MenACWY vaccine, with a booster shot at the age of 16. Teens may
Meningococcal Vaccines Market Development Trends, Key Manufacturers and Competit …
Meningococcal is a deadly disease is not taken care of immediately. The disease is majorly present in the teenage group and is caused by bacterial meningitis. It is basically an inflammation lining of the brain and spinal cord. There are three types of vaccines available for meningitis one of which is sold as menomune, menactra, and Bexsero and Trumenba. Annually, 2000-2600 teenagers are affected from this disease. Among these, one
Vaccines Market 2018 - 2025: Top 21 Vaccines Analysis Prevnar/Prevnar 13, Gardas …
A report added to the rich database of Qurate Business Intelligence, titled “Global Vaccines Industry, 2018 Market Research Report”, provides a 360-degree overview of the worldwide market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the data reliable in context to particular
Global Meningococcal Vaccines Market by Combination-, Conjugate-, Polysaccharide …
The global meningococcal vaccines market is estimated to reach US$ 4.3 Bn in 2021, expanding at a CAGR of 12.6% from 2017 to 2021, due to technological advancement and its rapid adoption worldwide. Browse Meningococcal Vaccines Market by Meningococcal Combination Vaccines (Bexsero, Trumenba, MenHibrix, Menitorix); Meningococcal Conjugate Vaccines (Menactra, MenAfriVac, Meningitec, Menjugate, Menveo, NeisVac-C, Nimenrix, NmVac4-DT); and Meningococcal Polysaccharide Vaccine (Bi Meningo, Mencevax, Menomune, NmVac4, Quadri Meningo) and Forecast 2017-2021